Literature DB >> 12065310

H+-peptide cotransport in the human bile duct epithelium cell line SK-ChA-1.

Ilka Knütter1, Isabel Rubio-Aliaga, Michael Boll, Gerd Hause, Hannelore Daniel, Klaus Neubert, Matthias Brandsch.   

Abstract

This study describes for the first time the presence of H+-peptide cotransport in cells of the bile duct. Uptake of [glycine-1-14C]glycylsarcosine ([14C]Gly-Sar) in human extrahepatic cholangiocarcinoma SK-ChA-1 cells was stimulated sevenfold by an inwardly directed H+ gradient. Transport was mediated by a low-affinity system with a transport constant (Kt) value of 1.1 mM. Several dipeptides, cefadroxil, and delta-aminolevulinic acid, but not glycine and glutathione, were strong inhibitors of Gly-Sar uptake. SK-ChA-1 cells formed tight, polarized monolayers on permeable membranes. The transepithelial electrical resistance was 856 +/- 29 omega x cm(2). The transepithelial flux of [14C]Gly-Sar in apical-to-basolateral direction exceeded the basolateral-to-apical flux 11-fold. Uptake was 20-fold higher from the apical side. RT-PCR analysis using primer pairs specific for the intestinal-type peptide transporter (PEPT1) or kidney-type (PEPT2) revealed that the transport system expressed in SK-ChA-1 and also in cells of the native rabbit bile duct is PEPT1. Immunohistochemistry localized PEPT1 to the apical membrane of cholangiocytes of mouse extrahepatic biliary duct. We conclude that the cells of the mammalian extrahepatic biliary tract epithelium express the intestinal-type H+-peptide cotransporter in their apical membrane. SK-ChA-1 cells represent a convenient model to study the physiological and clinical aspects of peptide transport in cholangiocytes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065310     DOI: 10.1152/ajpgi.00534.2001

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  14 in total

Review 1.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Authors:  Lucy Sanchez-Covarrubias; Lauren M Slosky; Brandon J Thompson; Thomas P Davis; Patrick T Ronaldson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

2.  Effect of dose escalation on the in vivo oral absorption and disposition of glycylsarcosine in wild-type and Pept1 knockout mice.

Authors:  Dilara Jappar; Yongjun Hu; David E Smith
Journal:  Drug Metab Dispos       Date:  2011-08-31       Impact factor: 3.922

3.  An in vivo role of Mrp2 in the rat hepatocytes by immunocytochemistry for amoxicillin using the transporter-deficient EHBR.

Authors:  Kunio Fujiwara; Masashi Shin; Yohei Yoshizaki; Tsubasa Miyazaki; Tetsuya Saita
Journal:  J Mol Histol       Date:  2012-03-25       Impact factor: 2.611

Review 4.  Function, Regulation, and Pathophysiological Relevance of the POT Superfamily, Specifically PepT1 in Inflammatory Bowel Disease.

Authors:  Emilie Viennois; Adani Pujada; Jane Zen; Didier Merlin
Journal:  Compr Physiol       Date:  2018-03-25       Impact factor: 9.090

5.  Influence of fed-fasted state on intestinal PEPT1 expression and in vivo pharmacokinetics of glycylsarcosine in wild-type and Pept1 knockout mice.

Authors:  Ke Ma; Yongjun Hu; David E Smith
Journal:  Pharm Res       Date:  2011-09-09       Impact factor: 4.200

6.  PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.

Authors:  Guillaume Dalmasso; Laetitia Charrier-Hisamuddin; Hang Thi Thu Nguyen; Yutao Yan; Shanthi Sitaraman; Didier Merlin
Journal:  Gastroenterology       Date:  2007-10-17       Impact factor: 22.682

7.  Targeted disruption of the peptide transporter Pept2 gene in mice defines its physiological role in the kidney.

Authors:  Isabel Rubio-Aliaga; Isabelle Frey; Michael Boll; David A Groneberg; Hans M Eichinger; Rudi Balling; Hannelore Daniel
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

Review 8.  Bile formation and secretion.

Authors:  James L Boyer
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

9.  Expression profile and functional activity of peptide transporters in prostate cancer cells.

Authors:  Wanyi Tai; Zhijin Chen; Kun Cheng
Journal:  Mol Pharm       Date:  2012-09-21       Impact factor: 4.939

Review 10.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.